Indehaveren af markedsføringstilladelsen afgav mundtlige redegørelser den 18. januar, den 15. februar og den 25. maj 2005.
(44-20) 74 18 84 00 Fax (44-20) 74 18 86 68 E-mail: mail@emea. eu. int http: / /www. emea. eu. int  EMEA 2005 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Upon consideration of all available data, the CHMP adopted an opinion for celecoxib on 23 June 2005 recommending the maintenance of the Marketing Authorisations for celecoxib containing medicinal products in the indications stated in the Summary of Product Characteristics as set out in Annex III.